Equity Overview
Price & Market Data
Price: $12.87
Daily Change: +$0.03 / 0.23%
Daily Range: $12.79 - $13.05
Market Cap: $153,217,344
Daily Volume: 69,390
Performance Metrics
1 Week: 2.06%
1 Month: -1.83%
3 Months: -6.81%
6 Months: 18.95%
1 Year: 167.6%
YTD: 43.96%
Company Details
Employees: 140
Sector: Health technology
Industry: Medical specialties
Country:
Details
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System. The company offers LENSAR Laser System which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.